Long-term survival after lung-sparing total pleurectomy for locally advanced (international mesothelioma interest group stage T3-T4) non-sarcomatoid malignant pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 5, 2012, Pages 1031-1036

  Nakas, Apostolos ^a   Meyenfeldt, Eric von ^a   Lau, Kelvin ^a   Muller, Salli ^a   Waller, David ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Extrapleural pneumonectomy; Malignant pleural mesothelioma; Pleurectomy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE INTERVAL; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; HUMAN; LENGTH OF STAY; LONG TERM SURVIVAL; LUNG EMBOLISM; LUNG INFECTION; LUNG RESECTION; LUNG SPARING TOTAL PLEURECTOMY; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PLEURECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SEPSIS; SURGICAL MORTALITY; SURVIVAL TIME; THORAX DRAINAGE; TREATMENT OUTCOME; CANCER STAGING; COMPARATIVE STUDY; EVALUATION; MESOTHELIOMA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; LENGTH OF STAY; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863824656     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr192     Document Type: Article

References (25)

1. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
2. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM,Corson JM et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63; discussion 63-5.
3. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P et al. Guidelines of the European Respiratory Soc iety and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. European Respiratory Society/European Society of Thoracic Surgeons Task Force. Eur Respir J 2010;35:479-95.
4. Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 1993;103:382S-4.
5. Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT et al. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.Eur J Cardiothorac Surg 2011;40:298-303.
6. Pass H. Surgery and mesothelioma: if not randomization, at least standardization and registration!. Lung Cancer 2011;71:1-2.
7. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-95.
8. Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument. Ann Surg Oncol 2007;14:1249-53.
9. Sugarbaker DJ. Editorial comment. Eur J Cardiothorac Surg 2007;31:770-1.
10. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M et al.Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135:620-6, 626.e1-3.
11. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 2007;31:765-70; discussion 770-1.
12. Chapman A, Mulrennan S, Ladd B, Muers MF. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax 2008;63:435-9.
13. Treasure T, Waller D, Tan C, Entwisle J, O'Brien M, O'Byrne K et al. The mesothelioma and radical surgery randomized controlled trial: the Mars feasibility study. J Thorac Oncol 2009;4:1254-8.
14. Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 1998;115:310-7; discussion 317-8.
15. Balduyck B, Trousse D, Nakas A, Martin-Ucar AE, Edwards J, Waller DA.Therapeutic surgery for nonepithelioid malignant pleural mesothelioma:is it really worthwhile?. Ann Thorac Surg 2010;89:907-11.
16. Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Jänne PA et al.Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys 2007;68:1366-74.
17. Stevens CW, Wong PF, Rice D, Jeter M, Forster K, Zhu XR. Treatment planning system evaluation for mesothelioma IMRT. Lung Cancer 2005;49:S75-81.
18. Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR et al.Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24:1561-7.
19. Nakas A, Martin Ucar AE, Edwards JG, Waller DA. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008;33:83-8.
20. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg 2008;34:886-91.
21. Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A,Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma:radical pleurectomy, chemotherapy with cisplatin/pemetrexed and radiotherapy. Lung Cancer 2011;71:75-81.
22. Cardillo G, Carleo F, Carbone L, Di Martino M, Salvadori L, Petrella L et al. Chronic postpneumonic pleural empyema: comparative merits of thoracoscopic versus open decortication. Eur J Cardiothorac Surg 2009;36:914-8.
23. Nakas A, Black E, Entwisle J, Muller S, Waller DA. Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?. Eur J Cardiothorac Surg 2010;37:1457-63.
24. Kopec SE, Irwin RS, Umali-Torres CB, Balikian JP, Conlan AA. The postpneumonectomy state. Chest 1998;114:1158-84.
25. Teh E, Fiorentino F, Tan C, Treasure T. A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med 2011;104:69-80.